These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1992636)

  • 21. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 22. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
    Castot A; Bidault I; Dahan R; Efthymiou ML
    Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
    Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk for developing tumors in therapy with the proton pump inhibitor omeprazole].
    Eissele R; Arnold R
    Versicherungsmedizin; 1993 Aug; 45(4):126-9. PubMed ID: 8379045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Miederer SE
    Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
    [No Abstract]   [Full Text] [Related]  

  • 27. The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly.
    Pilotto A; Di Mario F; Battaglia G; Vigneri S; Leandro G; Franceschi M; De Boni M; Grasso A; Vianello F; Naccarato R
    Clin Ther; 1994; 16(6):935-41. PubMed ID: 7697690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect and tolerability of omeprazole in the treatment of duodenal ulcer disease.
    Rinetti M; Vezzadini P; Jonsson E; Tomassetti P; Labó G
    Drugs Exp Clin Res; 1986; 12(8):701-5. PubMed ID: 3530677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study.
    Montemurro NE; Di Maggio A; Loperfido A; Franceschi M; Scatizzi A
    Clin Nephrol; 1993 Nov; 40(5):296-8. PubMed ID: 8281719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
    Annibale B; D'Ambra G; Luzzi I; Marcheggiano A; Iannoni C; Paoletti M; Anania MC; Marignani M; Delle Fave G
    Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bendamustine-associated hemolytic anemia.
    Glance LE; Cumpston A; Kanate A; Remick SC
    Ann Pharmacother; 2009 Nov; 43(11):1903-6. PubMed ID: 19809007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole and the development of acute hepatitis.
    Koury SI; Stone CK; La Charité DD
    Eur J Emerg Med; 1998 Dec; 5(4):467-9. PubMed ID: 9919455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical safety of omeprazole.
    Sölvell L
    Digestion; 1990; 47 Suppl 1():59-63; discussion 76. PubMed ID: 2093017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A severe case of cefoxitin-induced immune hemolytic anemia.
    Leaf DE; Langer NB; Markowski M; Garratty G; Diuguid DL
    Acta Haematol; 2010; 124(4):197-9. PubMed ID: 21042010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.
    Quintanilla-Bordás C; Castro-Izaguirre E; Carcelén-Gadea M; Marín M
    Transfusion; 2019 May; 59(5):1648-1650. PubMed ID: 30702749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phenacetin-induced hemolytic anemia misdiagnosed as unstable hemoglobinopathy].
    Kato H; Yamasita E; Fujino Y; Tokuhiro H
    Rinsho Ketsueki; 1992 Aug; 33(8):1036-40. PubMed ID: 1404859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.